The drug-eluting stent market size will grow up to USD 1.57 billion at a CAGR of 4.67% during 2021-2025.
This drug-eluting stent market analysis report entails exhaustive statistical qualitative and quantitative data on type (polymer free coating and polymer-based coating) and geography (North America, Europe, Asia, and ROW) and their contribution to the target market. View our sample report to gather market insights on the segmentations. Furthermore, with the latest key findings on the post COVID-19 impact on the market, available in this report, you can create successful business strategies to generate new sales opportunities.
What will the Drug-Eluting Stent Market Size be in 2021?
Browse TOC and LoE with selected illustrations and example pages of Drug-Eluting Stent Market
"North America will generate growth across all the years of the forecast period between 2020 and 2025. The year-on-year growth during this period will vary between 3.78% and 4.89%."
Drug-Eluting Stent Market: Key Drivers and Trends
Key drivers such as the high prevalence of atherosclerosis are notably supporting the drug-eluting stent market growth. However, one of the foremost factors impeding market growth is the decline in the price of drug-eluting stents. Get detailed insights on the trends and challenges to stay prepared for the obstacles in the future, which will help companies analyze and develop growth strategies.
This drug-eluting stent market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. Get detailed insights on the trends and challenges, which will help companies evaluate and develop growth strategies.
Market Overview
The parent, global healthcare supplies market, covers products and companies engaged in R&D of a variety of product categories spanned across medical consumables that are used for the diagnosis and treatment of various diseases. Technavio calculates the global healthcare supplies market size based on the combined revenue generated by manufacturers of medical supplies such as syringes, drapes, gloves, and gowns. Growth in the global healthcare supplies market will be driven by the following factors: Increasing life expectancy.
Who are the Major Drug-Eluting Stent Market Vendors?
The report analyzes the market’s competitive landscape and offers information on several market vendors, including:
- Abbott Laboratories
- Biosensors International Group Ltd.
- BIOTRONIK SE & Co. KG
- Boston Scientific Corp.
- Concept Medical Inc.
- Cook Medical LLC
- Lepu Medical Technology (Beijing) Co. Ltd.
- Medtronic Plc
- Meril Life Sciences Pvt. Ltd.
- Terumo Corp.
From our Porter’s five forces analysis study, get detailed insights on the functional involvement of the buyers and suppliers to form well-rounded knowledge about the supply chain and create cost reduction plans. The drug-eluting stent market analysis report also contains exhaustive observation on the organic and inorganic growth strategies deployed by the vendors. Click here to uncover details of successful business strategies adopted by the vendors.
Furthermore, to make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments. Buy the full drug-eluting stent market statistics report to understand the magnitude of the economic impact on each segment and recovery expectations.
Download a free sample of the drug-eluting stent market forecast report for insights on complete key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
Which are the Key Regions for Drug-Eluting Stent Market?
For more insights on the market share of various regions Request for a FREE sample now!
The drug-eluting stent market size, share, & trends analysis report offers an up-to-date study of the geographical composition of the market. 32% of the market’s growth will originate from North America during the forecast period. The US is the key market for drug-eluting stents in North America.
North America has been recording a significant growth rate and is expected to offer several business opportunities to market vendors during the forecast period. One of the key factors driving the growth in North America is the favorable reimbursement scenario. To garner further competitive intelligence and regional opportunities in store for vendors, view our sample report.
What are the Revenue-generating Type Segments in the Drug-Eluting Stent Market?
To gain further insights on the market contribution of various segments Request for a FREE sample!
The drug-eluting stent market share growth by the polymer free coating segment has been significant. The drug-eluting stent market report provides a comprehensive understanding of the subsegments of the target market to identify niche customer groups and demographic requirements. Furthermore, the report provides insights on the impact of COVID-19 on market segments, which can be used to deduce transformation patterns in consumer behavior in the coming years and improvise business plans.
This report provides thorough drug-eluting stent market segment analysis that will help you gauge the existing competition, demographics, lucrative target customer groups, solutions to improve sales and services, and other crucial market intelligence data. Request for a free sample of the report to get an exclusive glimpse of actionable market insights on post COVID-19 impact on each segment and the growth of the drug-eluting stent market size.
|
Drug-Eluting Stent Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
120 |
|
Base year |
2020 |
|
Forecast period |
2021-2025 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 4.67% |
|
Market growth 2021-2025 |
$ 1.57 billion |
|
Market structure |
Fragmented |
|
YoY growth (%) |
4.24 |
|
Regional analysis |
North America, Europe, Asia, and ROW |
|
Performing market contribution |
North America at 32% |
|
Key consumer countries |
US, UK, China, Germany, and Japan |
|
Competitive landscape |
Leading companies, competitive strategies, consumer engagement scope |
|
Companies profiled |
Abbott Laboratories, Biosensors International Group Ltd., BIOTRONIK SE & Co. KG, Boston Scientific Corp., Concept Medical Inc., Cook Medical LLC, Lepu Medical Technology (Beijing) Co. Ltd., Medtronic Plc, Meril Life Sciences Pvt. Ltd., and Terumo Corp. |
|
Market Dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for the forecast period, |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
What are the Key Factors Covered in this Drug-Eluting Stent Market Report?
- CAGR of the market during the forecast period 2021-2025
- Detailed information on factors that will drive drug-eluting stent market growth during the next five years
- Precise estimation of the drug-eluting stent market size and its contribution to the parent market
- Accurate predictions on upcoming trends and changes in consumer behavior
- The growth of the drug-eluting stent market across North America, Europe, Asia, and ROW
- A thorough analysis of the market’s competitive landscape and detailed information on vendors
- Comprehensive details of factors that will challenge the growth of drug-eluting stent market vendors
We can help! Our analysts can customize this report to meet your requirements. Get in touch